Lupin launches generic Doxercalciferol injection in US
The injection is used for treatment of hyperparathyroidism
Lupin has launched its generic Doxercalciferol injection used for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
IIT Hyderabad CfHE Fellow launches vaccination clinic in Pune
The clinic was launched in collaboration with Gates Foundation; the concept will take vaccination to schools, colleges and…
Panacea Biotec bags $24.32 m award from UN Agencies
The company received the award for its Easyfive-TT, which was introduced as fully liquid wP-based pentavalent vaccine in the…
SPARC signs pact with Bioprojet
To acquire exclusive rights for drug to treat auto-immune diseases
Sun Pharma Advanced Research Company (SPARC) has entered a…
Sai Life Sciences appoints Jay Stella as Chief Business Officer
Stella brings over 25 years of leadership in the pharmaceutical and medical devices industries
Sai Life Sciences announced the…
Lupin’s arm Nanomi completes stake divestment in Kyowa Pharma
Lupin said the transaction generates post tax net cash inflow of around JPY 33,429 million (Rs 2,157.6 crore) and significantly…
ICRA maintains stable outlook for Indian pharma companies
Domestic pharma cos expected to grow at a CAGR of around 10-12 per cent between FY2019-2022
ICRA has maintained a stable…
Gilead Sciences awards grants to address HIV challenges in India
Four Indian recipients out of 39 submissions to receive the grant
Gilead Sciences announced the recipients of its 2019 Gilead…
Eminence Business Media to organise Pharma Authors Round Table in Mumbai
Project managers are invited to submit their abstracts of white papers by or before January 7, 2020
Eminence Business Media is…
Hetero launches TAFFIC, the latest 3-in-1 single pill for HIV treatment.
The 3-in-1 combination drug helps to prevent HIV from multiplying and works together to decrease the amount of HIV in the…